主管单位:中华人民共和国
国家卫生健康委员会
主办单位:中国医师协会
总编辑:杨秋
编辑部主任:吴翔宇
邮发代号:80-528
定价:28.00元
全年:336.00元
Email:zgyy8888@163.com
电话(传真):010-64428528;
010-64456116(总编室)
英文作者:Tan Qingjing1 Zhang Xue2 Dou Weihua1 Yang Junwei1 Wei Yufei1 Gu Lian1
单位:1广西中医药大学第一附属医院脑病科,南宁530023;2广西中医药大学,南宁530001
英文单位:1Department of Encephalopathy the First Affiliated Hospital of Guangxi University of Chinese Medicine Nanning 530023 China; 2Guangxi University of Chinese Medicine Nanning 530001 China
英文关键词:Ischemicstroke;Inflammation;MicroRNA;Signalpathway
炎症反应是缺血性脑卒中(IS)发生发展的重要因素。其中微小RNA(miR)是基因表达的重要调控因子,可调节相关信号蛋白水平,激活或抑制相关炎症信号通路,在IS引起的炎症反应中发挥关键作用,可作为诊断和治疗IS的分子靶点。中药多组分、多靶点、多通路的特点在临床治疗IS中取得显著的效果,部分中药提取物、中药复方可通过调控miR及炎症信号通路,改善IS炎症损伤,起到神经保护作用,展现出巨大研究前景。本文结合中医药现代研究,以miR及炎症信号通路为切入点,对miR及其相关信号通路参与IS炎症,以及中医药干预炎症反应的具体分子机制作一综述,以期为IS的防治及后续研究提供参考。
Inflammatory response is an important factor in the development of ischemic stroke (IS). Among them, microRNA (miR) is an important regulator of gene expression, which can regulate the level of related signal proteins, activate or inhibit related inflammatory signaling pathways, plays a key role in the inflammatory response caused by IS, and can be used as a molecular target for the diagnosis and treatment of IS. The characteristics of multi-component, multi-target and multi-pathway of traditional Chinese medicine have achieved remarkable results in the clinical treatment of IS. Some traditional Chinese medicine extracts and compounds can improve IS inflammatory injury by regulating miR and inflammatory signaling pathways, and play a neuroprotective role, showing great research prospects. Based on the modern research of traditional Chinese medicine, this paper takes miR and inflammatory signaling pathway as the starting point, and reviews the specific molecular mechanism of miR molecules, miR regulation related signaling pathways involved in IS inflammation, and traditional Chinese medicine intervention in inflammatory response, in order to provide reference for the prevention and treatment of IS and follow-up research.
copyright 《中国医药》杂志编辑部
地址:北京市朝阳区安贞路2号首都医科大学附属北京安贞医院北楼二层
电话:010-64456116 传真:010-64428528 邮编:100029 Email: zgyy8888@163.com
网址:www.chinamedicinej.com 京ICP备2020043099号-3
当您在使用本网站投稿遇到困难时,请直接将稿件投送到编辑部邮箱zgyy8888@163.com。